NCT06039111View on ClinicalTrials.gov

Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Vulvar Cancer
Interventions
PROCEDURE

ICG alone

SLNs will be detected with ICG alone, labelled as such, and subsequent to that tested with Gamma probe for accuracy

All Listed Sponsors
collaborator

Juravinski Cancer Centre Foundation

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT06039111 - Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter